856. Do Antifungals Work in a Persistently Neutropenic Patient? NO
Session: Symposium: Great Debates in Mycology
Saturday, October 22, 2011: 11:30 AM
Room: 205ABC


Michael Kleinberg, MD, University of Maryland School of Medicine, Baltimore, MD

Michael Kleinberg, M.D. Ph.D. POSITION TITLE: Associate Professor of Medicine Head, Infectious Diseases Section, University of Maryland Greenebaum Cancer Center EDUCATION/TRAINING: Albert Einstein College Of Medicine, Bronx, NY M.D./Ph.D 1977-1984 Internal Medicine Residency, Cornell University Medical College, New York, NY 1984-1986 Infectious Diseases fellowship: NIAID, NIH, Bethesda, MD 1986-1989 PROFESSIONAL EXPERINCE: Instructor in Medicine, Univerity of Maryland School of Medicine, Baltimore, MD 1989-1990 Assistant Professor, University of Maryland School of Medicine 1990-1998 Associate Professor, University of maryland School of Medicine 1998-present CLINICAL AND RESEARCH INTERESTS: My clinical activities include the prevention and treatment of infections in patients with hematological and other malignancies and in recipients of stem cell transplants. A major initiative is building a cancer center-wide enterprise emcompassing quality initiatives in infectious diseases, infection control, anti-infective stewardship, and patient/staff education. My research interests are focused on broad-based outcomes measures for oncology patients treated for viral, bacterial, and fungal infections and in optimizing treatment in cancer patients co-infected with HIV and other chronic viral infections. In addition, I have a keen long-term interest in developing clinical prediction tools for optimizing anti-infective treatment strategies in individual immunocompromised patients.



See more of: Great Debates in Mycology
See more of: Symposium
<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.